Ruxolitinib in steroid refractory graft-vs.-host disease: a case report

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is potentially curative in a variety of hematological malignancies. Graft-vs.-host disease (GvHD) remains a life-threatening complication. Standard treatment is high-dose (HD) corticosteroids. Steroid-refractory (SR) GvHD is assoc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Hematol Oncol
Auteurs principaux: Maffini, Enrico, Giaccone, Luisa, Festuccia, Moreno, Brunello, Lucia, Buondonno, Ilaria, Ferrero, Dario, Boccadoro, Mario, Dellacasa, Chiara, Busca, Alessandro, Novero, Domenico, Bruno, Benedetto
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977623/
https://ncbi.nlm.nih.gov/pubmed/27502249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0298-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires